# Kiniksa Pharmaceuticals International, plc > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/kiniksa-pharmaceuticals-international-plc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 27 | | Claims under review | 1 | | Evidence records | 9 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:51:55.971604+00:00 | | Last reviewed | 2026-10-16T13:51:55.971604+00:00 | ## Identity - Legal name: Kiniksa Pharmaceuticals International, plc - Display name: Kiniksa Pharmaceuticals International, plc ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T18:26:56.985687+00:00 | | Completeness | 0.409 | | Record Quality | 0.849 | | Directors | 10 | | Committees | 4 | | Governance events | 22 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Barry D. Quart, Pharm.D.: Director. Status: current. Independent: true. Since: 2015-01-01. claim_id=alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:5 - Felix J. Baker, Ph.D.: Director. Status: current. Independent: true. Since: 2015-01-01. claim_id=alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:6 - G. Bradley Cole: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (member). claim_id=alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:7 - Kimberly J. Popovits: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Compensation (chair); Compensation · Chair (member). claim_id=alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:8 - Meredith S. Boyd: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:9 - Richard S. Levy, M.D.: Director. Status: current. Independent: true. Since: 2019-01-01. claim_id=alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:10 - Sanj K. Patel: Director. Status: current. Independent: false. Since: 2015-01-01. claim_id=alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:11 - Stephen R. Biggar, Ph.D.: Director. Status: current. Independent: true. Since: 2015-01-01. claim_id=alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:12 - Thomas R. Malley: Director. Status: current. Independent: true. Since: 2016-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:13 - Tracey L. McCain: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Audit (member). claim_id=alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:14 ## Committees - Audit (audit). Chair: Thomas R. Malley. Members: Thomas R. Malley (chair, current); G. Bradley Cole (member, current); Tracey L. McCain (member, current). committee_id=alpha:committee:kiniksa-pharmaceuticals-international-plc:audit - Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Thomas R. Malley (member, current). committee_id=alpha:committee:kiniksa-pharmaceuticals-international-plc:audit-chair - Compensation (compensation). Chair: Kimberly J. Popovits. Members: Kimberly J. Popovits (chair, current); Meredith S. Boyd (member, current). committee_id=alpha:committee:kiniksa-pharmaceuticals-international-plc:compensation - Compensation · Chair (compensation). Chair: NOT_PUBLISHED. Members: Kimberly J. Popovits (member, current). committee_id=alpha:committee:kiniksa-pharmaceuticals-international-plc:compensation-chair ## Executive leadership - Eben Tessari: Executive Vice President and Chief Strategy Officer. Status: current. claim_id=alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:15 - John F. Paolini: Executive Vice President and Chief Medical Officer. Status: current. claim_id=alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:16 - Mark Ragosa: Executive Vice President and Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:17 - Michael Megna: Senior Vice President, Chief Accounting Officer [CAO]. Status: current. claim_id=alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:18 - Ross Moat: Executive Vice President and Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:19 - Sanj K. Patel: Chief Executive Officer and Chairman of the Board [CEO]. Status: current. claim_id=alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:20 ## Governance events - EXECUTIVE_APPOINTED: Eben Tessari executive of Kiniksa Pharmaceuticals International, plc, effective 2026-04-16. Effective: 2026-04-16. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:149447i93o45u - EXECUTIVE_APPOINTED: John F. Paolini executive of Kiniksa Pharmaceuticals International, plc, effective 2026-04-16. Effective: 2026-04-16. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:1t39c5w1u5t392 - CFO_CHANGED: Mark Ragosa executive of Kiniksa Pharmaceuticals International, plc, effective 2026-04-16. Effective: 2026-04-16. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:14b8a90huly52 - EXECUTIVE_APPOINTED: Michael Megna executive of Kiniksa Pharmaceuticals International, plc, effective 2026-04-16. Effective: 2026-04-16. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:1ca496h1pgo7w1 - EXECUTIVE_APPOINTED: Ross Moat executive of Kiniksa Pharmaceuticals International, plc, effective 2026-04-16. Effective: 2026-04-16. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:15gvrg7v7m9zp - CEO_CHANGED: Sanj K. Patel executive of Kiniksa Pharmaceuticals International, plc, effective 2026-04-16. Effective: 2026-04-16. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:pjpckid2d8cc - DIRECTOR_APPOINTED: Meredith S. Boyd seat on Kiniksa Pharmaceuticals International, plc, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:9azvl610lft7a - COMMITTEE_MEMBER_ADDED: Meredith S. Boyd member of Compensation, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:1qd4x5wifx858 - DIRECTOR_APPOINTED: G. Bradley Cole seat on Kiniksa Pharmaceuticals International, plc, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:sgutl4mvijos - COMMITTEE_MEMBER_ADDED: G. Bradley Cole member of Audit, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:zu35or1be2eix - DIRECTOR_APPOINTED: Richard S. Levy, M.D. seat on Kiniksa Pharmaceuticals International, plc, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:3jbuhmrspnfo - DIRECTOR_APPOINTED: Kimberly J. Popovits seat on Kiniksa Pharmaceuticals International, plc, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:b64kpa8tlz7o - DIRECTOR_APPOINTED: Tracey L. McCain seat on Kiniksa Pharmaceuticals International, plc, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:1v32a8t1nmrf25 - COMMITTEE_CREATED: Compensation · Chair committee of Kiniksa Pharmaceuticals International, plc, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:1nx8hi21rspnt8 - COMMITTEE_MEMBER_ADDED: Kimberly J. Popovits member of Compensation · Chair, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:10xdk8d11f3yad - DIRECTOR_APPOINTED: Thomas R. Malley seat on Kiniksa Pharmaceuticals International, plc, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:17muucs1ofhyk4 - COMMITTEE_CREATED: Audit · Chair committee of Kiniksa Pharmaceuticals International, plc, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:bnkp6i1d0ciz4 - COMMITTEE_MEMBER_ADDED: Thomas R. Malley member of Audit · Chair, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:7ddj64yy0og - DIRECTOR_APPOINTED: Barry D. Quart, Pharm.D. seat on Kiniksa Pharmaceuticals International, plc, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:mlp0yy1drwuk4 - DIRECTOR_APPOINTED: Felix J. Baker, Ph.D. seat on Kiniksa Pharmaceuticals International, plc, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:1seb4j71wsbx57 - DIRECTOR_APPOINTED: Sanj K. Patel seat on Kiniksa Pharmaceuticals International, plc, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:bovesxbq2xnp - DIRECTOR_APPOINTED: Stephen R. Biggar, Ph.D. seat on Kiniksa Pharmaceuticals International, plc, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T13:51:55.971604+00:00. event_id=alpha:event:transition:1xrz02493n6y2 ## Scoped resources - `alpha://company/kiniksa-pharmaceuticals-international-plc` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record - `alpha://company/kiniksa-pharmaceuticals-international-plc/identity` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=identity - `alpha://company/kiniksa-pharmaceuticals-international-plc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=corporate-structure - `alpha://company/kiniksa-pharmaceuticals-international-plc/board` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=board - `alpha://company/kiniksa-pharmaceuticals-international-plc/committees` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=committees - `alpha://company/kiniksa-pharmaceuticals-international-plc/leadership` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=leadership - `alpha://company/kiniksa-pharmaceuticals-international-plc/ownership` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=ownership - `alpha://company/kiniksa-pharmaceuticals-international-plc/financials` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=financials - `alpha://company/kiniksa-pharmaceuticals-international-plc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=capital-structure - `alpha://company/kiniksa-pharmaceuticals-international-plc/compensation` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=compensation - `alpha://company/kiniksa-pharmaceuticals-international-plc/governance` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=governance - `alpha://company/kiniksa-pharmaceuticals-international-plc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=shareholder-governance - `alpha://company/kiniksa-pharmaceuticals-international-plc/audit` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=audit - `alpha://company/kiniksa-pharmaceuticals-international-plc/legal` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=legal - `alpha://company/kiniksa-pharmaceuticals-international-plc/risk` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=risk - `alpha://company/kiniksa-pharmaceuticals-international-plc/cyber` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=cyber - `alpha://company/kiniksa-pharmaceuticals-international-plc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=ai-governance - `alpha://company/kiniksa-pharmaceuticals-international-plc/agents` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=agents - `alpha://company/kiniksa-pharmaceuticals-international-plc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=ecosystem - `alpha://company/kiniksa-pharmaceuticals-international-plc/events` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=events - `alpha://company/kiniksa-pharmaceuticals-international-plc/relationships` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=relationships - `alpha://company/kiniksa-pharmaceuticals-international-plc/assessments` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=assessments - `alpha://company/kiniksa-pharmaceuticals-international-plc/evidence` (contract): https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:thomas-r-malley","name":"Thomas R. Malley"},"source_id":"board_seats"}` - Claim alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:g-bradley-cole","name":"G. Bradley Cole"},"source_id":"board_seats"}` - Claim alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:tracey-l-mccain","name":"Tracey L. McCain"},"source_id":"board_seats"}` - Claim alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:kimberly-j-popovits","name":"Kimberly J. Popovits"},"source_id":"board_seats"}` - Claim alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:m-cantey-boyd","name":"Meredith S. Boyd"},"source_id":"board_seats"}` ## Leadership - Barry D. Quart, Pharm.D.: Director. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:5. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef. - Felix J. Baker, Ph.D.: Director. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:6. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef. - G. Bradley Cole: Director, Audit. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:7. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef. - Kimberly J. Popovits: Director, Compensation · Chair. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:8. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef. - Meredith S. Boyd: Director, Compensation. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:9. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef. - Richard S. Levy, M.D.: Director. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:10. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef. - Sanj K. Patel: Director. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:11. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef. - Stephen R. Biggar, Ph.D.: Director. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:12. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef. - Thomas R. Malley: Director, Audit · Chair. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:13. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef. - Tracey L. McCain: Director, Audit. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:14. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef. - Eben Tessari: Executive Vice President and Chief Strategy Officer. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:15. Valid from: 2026-04-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:16ab3874995173b77b20cc5299cd3af3ebadeb372c0541eb1da7103d812effc5. - John F. Paolini: Executive Vice President and Chief Medical Officer. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:16. Valid from: 2026-04-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4dea3fbb2b2db9cd44e3cc8688f93623c90cb4d554e102333cd604bb718baf37. - Mark Ragosa: Executive Vice President and Chief Financial Officer. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:17. Valid from: 2026-04-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d9e4db646bc39ea68ef6182197ff9bb92f94f6b49e3b40234e69d662e0ac9ef5. - Michael Megna: Senior Vice President, Chief Accounting Officer. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:18. Valid from: 2026-04-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fe47d0f47e092d3b20c3e325b8dad5e00d63c36f15b508b5f75fe7d727287089. - Ross Moat: Executive Vice President and Chief Operating Officer. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:19. Valid from: 2026-04-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5832c838c0e7cd3b8ec0b3752fdcab84324bc816406bee9124ae6fc55374d9a8. - Sanj K. Patel: Chief Executive Officer and Chairman of the Board. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:leadership_role:20. Valid from: 2026-04-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1abd925ef4dfe4186e183b05f87763002497554775e404a250d5189ba10580c0. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Thomas R. Malley; Members Thomas R. Malley (Chair); G. Bradley Cole; Tracey L. McCain. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9816b96641ce0b53444e46cad0f10b1a5e5f181131c9657c056a4922653012ad. - Compensation: Chair Kimberly J. Popovits; Members Kimberly J. Popovits (Chair); Meredith S. Boyd. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_record:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9816b96641ce0b53444e46cad0f10b1a5e5f181131c9657c056a4922653012ad. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Kiniksa Pharmaceuticals International, plc. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:33742b7a41b6c08e91156b8b3281d766164339d3eb939a6f2dfca760fbfd21ea. ## Entity Status - Public listing published. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:33742b7a41b6c08e91156b8b3281d766164339d3eb939a6f2dfca760fbfd21ea. ## Published Fact - US. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:33742b7a41b6c08e91156b8b3281d766164339d3eb939a6f2dfca760fbfd21ea. ## Committee Appointment - Thomas R. Malley: chair, Audit. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9816b96641ce0b53444e46cad0f10b1a5e5f181131c9657c056a4922653012ad. - G. Bradley Cole: member, Audit. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9816b96641ce0b53444e46cad0f10b1a5e5f181131c9657c056a4922653012ad. - Tracey L. McCain: member, Audit. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9816b96641ce0b53444e46cad0f10b1a5e5f181131c9657c056a4922653012ad. - Kimberly J. Popovits: chair, Compensation. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9816b96641ce0b53444e46cad0f10b1a5e5f181131c9657c056a4922653012ad. - Meredith S. Boyd: member, Compensation. Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9816b96641ce0b53444e46cad0f10b1a5e5f181131c9657c056a4922653012ad. ## Security Listing - KNSA (NASDAQ). Claim: alpha:claim:company:9011f721-f68e-4a71-b1b5-e505201f81cf:security_listing:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:33742b7a41b6c08e91156b8b3281d766164339d3eb939a6f2dfca760fbfd21ea. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:33742b7a41b6c08e91156b8b3281d766164339d3eb939a6f2dfca760fbfd21ea: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc). - alpha:projection-evidence:document:174bd0731c5423afa3a73d7466e4d0bcf5680d1611333ffea4f5bfc4de04e4ef: [Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16](https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm). - alpha:projection-evidence:document:16ab3874995173b77b20cc5299cd3af3ebadeb372c0541eb1da7103d812effc5: [KNSA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm). - alpha:projection-evidence:document:4dea3fbb2b2db9cd44e3cc8688f93623c90cb4d554e102333cd604bb718baf37: [KNSA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm). - alpha:projection-evidence:document:d9e4db646bc39ea68ef6182197ff9bb92f94f6b49e3b40234e69d662e0ac9ef5: [KNSA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm). - alpha:projection-evidence:document:fe47d0f47e092d3b20c3e325b8dad5e00d63c36f15b508b5f75fe7d727287089: [KNSA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm). - alpha:projection-evidence:document:5832c838c0e7cd3b8ec0b3752fdcab84324bc816406bee9124ae6fc55374d9a8: [KNSA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm). - alpha:projection-evidence:document:1abd925ef4dfe4186e183b05f87763002497554775e404a250d5189ba10580c0: [KNSA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm). - alpha:projection-evidence:9816b96641ce0b53444e46cad0f10b1a5e5f181131c9657c056a4922653012ad: [Audit](https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/kiniksa-pharmaceuticals-international-plc) - [Public Markdown](https://registry.alpha.ac/companies/kiniksa-pharmaceuticals-international-plc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/kiniksa-pharmaceuticals-international-plc?format=jsonld) - MCP resource: `alpha://companies/kiniksa-pharmaceuticals-international-plc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T18:26:56.781075+00:00; recorded 2026-10-16T18:26:56.781075+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.